Odyssey Health (ODYY) Total Debt Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Total Debt Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 30.59% |
| Jan 31, 2026 | 79.01% |
| Oct 31, 2025 | 65.86% |
| Jul 31, 2025 | 71.44% |
| Apr 30, 2025 | 27.91% |
| Jan 31, 2025 | 31.09% |
| Oct 31, 2024 | 33.85% |
| Jul 31, 2024 | 32.71% |
| Apr 30, 2024 | 34.84% |
| Jan 31, 2024 | 35.22% |
| Oct 31, 2023 | 48.00% |
| Jul 31, 2023 | 47.73% |
| Apr 30, 2023 | 46.01% |
| Jan 31, 2023 | 48.05% |
| Oct 31, 2022 | 45.23% |
| Jul 31, 2022 | 47.14% |
| Apr 30, 2022 | 38.66% |
| Jan 31, 2022 | 45.33% |
| Oct 31, 2021 | 41.58% |
| Jul 31, 2021 | 57.16% |